Get Free Consultation
Report has deep-dive into Digital Therapeutics (DTx) application in the management of chronic illness. Today’s global population is encountering numerous health problems, majority of them are suffering from chronic illnesses. Drug treatment is getting costlier, intolerable and sometimes even fatal, exploring other options becomes important now.
Digital Therapeutics (DTx) are therapeutic interventions that is based on evidence and driven by software to halt, manage, or treat a medical disorder or disease. Various indications being explored for the treatment. DTx entails various benefits, it can support patients is self-managing symptoms and thereby improve their quality of life. Due the proliferation of digital tools, rising digital literacy, changing digital landscape making its adaptability conducive. The DTx market is poised to rise nearly tenfold in the next four to seven years, with a projected market value of USD 10.6 billion (USD) by 2025.
- Defining Digital Therapeutics (DTx)
- Market Forecast
- Companies Focusing on Digital Therapeutics (DTx)
- Current Trends, Future Challenges in Developing Digital Therapeutics (DTx)
- Market Unmet Need and Opportunity Analysis
- Widely Accepted Indications for DTs Development (Congestive Heart Failure, Alzheimer's Disease, Type II Diabetes, Anxiety, Depression and many more)
- Companies Pipeline Portfolio Assessment
- Competitive Landscape
1. Infrastructure Service Providers
2. Network Connectivity and Hardware Providers
3. Platform, Services, Application Providers
- Clinical Trials Being Conducted by Academic and Industry Players
- Regulations for the Application of DTx
- Future Development
- Fostering Understanding on Digital Therapeutics (DTx) Treatment Landscape
- In Order to Understand the Market Potential
- Opportunity Analysis (exist in the market for players)
- Clinical Developments in the market
- To Know Current and Future Market Trends
- Key Players and their Key Strategic Move
Author: Ipseeta Dash: Education: National Institute of Pharmaceutical Education and Research (NIPER), Mohali. Expertise: Infectious Disease, Metabolic Disorders, Experience: Global Data, GSK, Indegene Life System